Siegfried Holding nominates new chairman

Siegfried Holding AG, a Swiss life sciences company, has proposed Beat Walti be elected chairman at the company’s annual shareholders meeting in April, 2026. Dr Walti is already a board member and would succeed Andreas Casutt, who has been Siegfried’s chairman since 2014. Dr Walti, an attorney, chairs the board of trustees of the Ernst Göhner Foundation, Siegfried’s largest shareholder. With board mandates at DSV A/S and Rahn AG, as chairman, he will drive the expansion of Siegfried’s market position. The company manufactures pharmaceutical APIs and drug products for the pharmaceutical industry.

Siegfried announced the appointment on 26 September 2025.